Skip to main content
Log in

Dopaminergic stimulation of HGH in diabetes mellitus and in obesity

  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

The behavior of HGH in basal conditions and after L-Dopa infusion was studied in a group of patients with diabetic retinopathy, in 9 obese and 8 control subjects. In both diabetics and obese subjects, increases found in HGH plasma levels after administration of the drug were slighter than in the controls. On the basis of these results it can be concluded that in diabetics the availability of energetic substrates may modify the HGH response to the L-Dopa stimulus. In obesity, the possibility is considered of a reversible defect in the sensitivity of the dopaminergic receptors, induced by metabolic and endocrine factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beck P., Koumas J. H. T., Winterling C. A.: Studies of Insulin and Growth Hormone Secretion in Human Obesity — J. Lab. clin. Med.64, 654, 1964.

    PubMed  CAS  Google Scholar 

  2. Boy A. E. III, Lebovitz H. E., Pfeiffer J. B.: Stimulation of Human-Growth-Hormone Secretion by L-Dopa — New Engl. J. Med.283, 1425, 1970.

    Article  Google Scholar 

  3. Brown M. E.: Ultra-Micro Sugar Determinations Using 2,9-Dimethyl-1,10-Phenantoine Hypochloride (Necuproine) — Diabetes10, 60, 1961.

    CAS  Google Scholar 

  4. Cavagnini F., Peracchi M., Scotti G., Raggi U., Pontiroli A. E., Bana R.: Effect of L-Dopa Administration on Growth Hormone Secretion in Normal Subjects and Parkinsonian Patients — J. Endocr.54, 425, 1972.

    Article  PubMed  CAS  Google Scholar 

  5. El-Khodary A. Z., Ball M. F., Stein B., Canary J. J.: The Effect of Weight Loss on the Growth Hormone Response to Arginine Infusion in Obesity — J. clin. Endocr.32, 42, 1971.

    PubMed  CAS  Google Scholar 

  6. Fingerhut M., Krieger D. T.: Plasma Growth Hormone Response to L-Dopa in Obese Subjects — Metabolism23, 267, 1974.

    Article  PubMed  CAS  Google Scholar 

  7. Frohman L. A., Stachura M. E.: Neuropharmacologic Control of Neuroendocrine Function in Man — Metabolism24, 211, 1975.

    Article  PubMed  CAS  Google Scholar 

  8. Hansen Aa. P.: Abnormal Serum GH Response to Exercise in Maturity-Onset Diabetics — Diabetes22, 619, 1973.

    PubMed  CAS  Google Scholar 

  9. Kansal P. C., Buse J., Talbert O. R., Buse M.: The Effect of L-Dopa on Plasma Growth Hormone, Insulin and Thyroxine — J. clin. Endocr.34, 99, 1972.

    PubMed  CAS  Google Scholar 

  10. Lessof M. H., Young S. M., Greenwood F. C.: Growth Hormone Secretion in Obese Subjects — Guy’s Hosp. Rep.115, 65, 1966.

    CAS  Google Scholar 

  11. Lundbæck K., Christensen N. J., Jensen V. A., Johansen K., Olsen T. S., Hansen Aa. P., Ørskov H., Østerby R.: Diabetes, Diabetic Angiopathy and Growth Hormone — Lancet2, 131, 1970.

    Article  Google Scholar 

  12. Mims R. B., Scott C. L., Modebe O. M., Bethune J. E. — Prevention of L-Dopa Induced Growth Hormone Stimulation by Hyperglycemia — J. clin. Endocr.37, 660, 1973.

    PubMed  CAS  Google Scholar 

  13. Molinatti G. M., Massara F., Strumia E., Pennisi F., Scassellati G. A., Vancheri L.: Radioimmunoassay of Human Growth Hormone — J. nucl. Biol. Med.13, 26, 1969.

    PubMed  CAS  Google Scholar 

  14. Muggeo M., Crepaldi G., Fedele D., Tiengo A.: Growth Hormone Secretion in Diabetic Retinopathy — Acta diabet. lat.10, 737, 1973.

    CAS  Google Scholar 

  15. Powell E. D., Frantz G. A., Rabkin M. T., Field R. A.: Growth Hormone in Relation to Diabetic Retinopathy — New Engl. J. Med.275, 922, 1966.

    Article  PubMed  CAS  Google Scholar 

  16. Roth J., Glick S. M., Yalow R. S., Berson S. A.: Secretion of Human Growth Hormone: Physiologic and Experimental Modification — Metabolism12, 577, 1963.

    PubMed  CAS  Google Scholar 

  17. Siber T. M., Vandenberg G., Yen S. S. C.: Inhibition of Growth Hormone Release in Human by Somatostatin — J. clin. Endocr.37, 632, 1973.

    Article  Google Scholar 

  18. Tchobroutsky G.: Plasma Growth Hormone Levels after Lunch in Diabetic and Non-Diabetic Subjects — Acta endocr. (Kbh.)74, 67, 1973.

    CAS  Google Scholar 

  19. Tchobroutsky G., Rosselin G., Assan R., Freychet P., Dérot M.: Growth Hormone Secretion in Obese Subjects with and without Diabetes. Comparison with Non-Obese Patients — In:Vague J. (Ed.): Physiopathology of Adipose Tissue. Excerpta Medica Foundation, Amsterdam, 1969; p. 269.

    Google Scholar 

  20. Yalow R. S., Glick S. M., Roth J., Berson S. A.: Plasma Insulin and Growth Hormone Levels in Obesity and Diabetes — Ann. N. Y. Acad. Sci.131, 357, 1965.

    Article  PubMed  CAS  Google Scholar 

  21. Yde H.: The Immunoreactive Growth Hormone in Serum from Patients with Various Types of Diabetes Mellitus — Acta endocr. (Kbh.)64, 339, 1970.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gragnoli, G., Palazzuoli, V., Favilli, R. et al. Dopaminergic stimulation of HGH in diabetes mellitus and in obesity. Acta diabet. lat 14, 137–143 (1977). https://doi.org/10.1007/BF02581401

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02581401

Key-words

Navigation